These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28763238)

  • 1. Method transfer: a CRO perspective.
    Hilhorst MJ; van der Strate BW; Briscoe CJ; van de Merbel NC
    Bioanalysis; 2017 Aug; 9(15):1131-1134. PubMed ID: 28763238
    [No Abstract]   [Full Text] [Related]  

  • 2. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
    Craddock A; Nadarajah S
    Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
    [No Abstract]   [Full Text] [Related]  

  • 3. Outsourcing strategy: local versus international contract research organizations.
    Zimmer D
    Bioanalysis; 2014 May; 6(10):1279-81. PubMed ID: 24958110
    [No Abstract]   [Full Text] [Related]  

  • 4. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 5. Driving external chemistry optimization via operations management principles.
    Bi FC; Frost HN; Ling X; Perry DA; Sakata SK; Bailey S; Fobian YM; Sloan L; Wood A
    Drug Discov Today; 2014 Mar; 19(3):289-94. PubMed ID: 23973340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contract research organizations. Their role in the development of clinical research.
    Harrison F
    Methods Find Exp Clin Pharmacol; 1998; 20 Suppl A():21-2. PubMed ID: 9800724
    [No Abstract]   [Full Text] [Related]  

  • 7. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
    Kros JF; Molis J
    Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
    [No Abstract]   [Full Text] [Related]  

  • 8. The emerging role of medical radiologists in new drug discovery.
    Wang YX
    Br J Radiol; 2005 Nov; 78(935):1058. PubMed ID: 16249612
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-World Data: An Unrealized Opportunity in Global Health?
    Barrett JS; Heaton PM
    Clin Pharmacol Ther; 2019 Jul; 106(1):57-59. PubMed ID: 31188467
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerating the Global Development of Pediatric Cancer Drugs: A Call to Coordinate the Submissions of Pediatric Investigation Plans and Pediatric Study Plans to the European Medicines Agency and US Food and Drug Administration.
    Reaman G; Karres D; Ligas F; Lesa G; Casey D; Ehrlich L; Norga K; Pazdur R
    J Clin Oncol; 2020 Dec; 38(36):4227-4230. PubMed ID: 32946356
    [No Abstract]   [Full Text] [Related]  

  • 11. Uniting Discovery and Care: The Role of Pharmaceutical Companies in Research, Clinical Studies, and Patient Care.
    Tan C; McGill JM; Mallbris L
    J Invest Dermatol; 2020 Mar; 140(3):527-530. PubMed ID: 31972248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmaceutical industry needs more clinical pharmacologists.
    Peck R
    Br J Clin Pharmacol; 2017 Nov; 83(11):2343-2346. PubMed ID: 28688130
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relationships between patient associations and companies: ethical aspects].
    Roche G
    Presse Med; 2012 May; 41 Suppl 1():S45-7. PubMed ID: 22459992
    [No Abstract]   [Full Text] [Related]  

  • 14. Compliance revisited: pharmaceutical drug trials in the era of the contract research organization.
    Jonvallen P
    Nurs Inq; 2009 Dec; 16(4):347-54. PubMed ID: 19906285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The RARE 2017 meeting for companies developing products for rare patients].
    Ferry A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():7. PubMed ID: 29911542
    [No Abstract]   [Full Text] [Related]  

  • 16. Institutional mistrust in the organization of pharmaceutical clinical trials.
    Fisher JA
    Med Health Care Philos; 2008 Dec; 11(4):403-13. PubMed ID: 18633728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contract Research Organizations (CROs) in China: integrating Chinese research and development capabilities for global drug innovation.
    Shi YZ; Hu H; Wang C
    Global Health; 2014 Nov; 10():78. PubMed ID: 25406839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From vaccine manufacturing to its availability in pharmacy].
    Soubeyrand B
    Rev Mal Respir; 2018 Dec; 35(10):1005-1019. PubMed ID: 30266457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group.
    Ménard T; Young K; Siegel L; Emerson J; Studt R; Sidor L;
    CPT Pharmacometrics Syst Pharmacol; 2021 Aug; 10(8):799-803. PubMed ID: 34247450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving with contemporary contract research.
    Chapman I
    Nat Rev Drug Discov; 2003 Jul; 2(7):597. PubMed ID: 12841192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.